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Abstract 
Background: Giant pituitary adenomas, with maximum diameter of at least 40 mm, continue to involve high surgical 
risks despite recent advances in microsurgical and/or endoscopic surgery. We treated a case of giant pituitary ade-
noma with preoperative endovascular embolization in an attempt to reduce blood loss.
Case presentation: A 48-year-old Japanese Woman presented with severe right visual disturbance. Magnetic reso-
nance imaging revealed a giant pituitary adenoma with maximum diameter of 82 mm. Angiography revealed signifi-
cant tumor stain, with blood supply mainly from the branches of the right meningohypophyseal trunk. These feeding 
arteries were endovascularly embolized with n-butyl cyanoacrylate. Subsequently, the tumor was safely removed by 
transsphenoidal surgery in two stages. The patient showed significant improvement of visual disturbance postopera-
tively, and was discharged without other neurological deficit. The surgical policy was explained preoperatively to the 
patients and written informed consents were obtained.
Conclusions: Preoperative embolization of a giant pituitary adenoma is a useful procedure that can potentially 
decrease the morbidity and mortality of this devastating tumor.
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Background
Pituitary adenomas are benign and grow slowly, but 
can extend and infiltrate into extrasellar areas, and may 
become very large before diagnosis. Pituitary adenomas 
with a diameter of more than 40  mm are classified as 
giant adenomas, and account for about 10% of all surgi-
cally treated pituitary adenomas [1–3]. Giant adenomas 
are associated with a higher frequency of neuro-oph-
thalmological symptoms, and postoperative pituitary 
apoplexy from this tumor is usually associated with very 
poor outcomes due to significant postoperative tumor 
swelling, hemorrhage, infarction, necrosis precipitat-
ing further mass effect, cerebral edema, and herniation 
syndrome [1, 4, 5]. The choice of the most appropriate 
surgical strategy should depend on the need to remove 
as much tumor as possible to improve the clinical symp-
toms and to minimize the risk of side effects.
Preoperative embolization of extra-axial tumors, such 
as meningiomas, is effective for decreasing blood loss, 
softening the tumor, and facilitating the surgery [6]. How-
ever, preoperative endovascular embolization has not 
been reported in giant pituitary adenomas. We describe 
a case of giant pituitary adenoma treated with preopera-
tive endovascular embolization, followed by successful 
removal via the transsphenoidal route, followed by neu-
rologic improvement of the patient.
Case presentation
History and examination
A 48-year-old Japanese Woman presented with a 
4-month history of progressive right visual disturbance. 
She had no history of other diseases. Ophthalmic exami-
nation revealed decreased visual acuity in both eyes. The 
right visual field showed generalized depression, and the 
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left visual field showed temporal hemianopsia. Neuro-
logical examination found no other abnormalities. Com-
puted tomography revealed a huge sellar tumor with 
extensive destruction of the midline skull base (Fig. 1a). 
Magnetic resonance imaging showed a well-demarcated 
mass with maximum diameter of 82 mm, extending from 
the sella to the interpeduncular cistern, with extensive 
destruction of the clivus. The both intracavernous carotid 
arteries were totally encased, and the roofs of the both 
cavernous sinuses were elevated superiorly. The tumor 
appeared hypointense on T1-weighted images and isoin-
tense on T2-weighted images, with marked enhancement 
with gadolinium (Fig.  1b–d). These neuroimaging fea-
tures were consistent with giant pituitary adenoma.
All biochemical parameters and hormonal status were 
within the normal ranges except for slight elevation of 
the prolactin value. Cerebral angiography demonstrated 
a hypervascular tumor with thick feeding arteries aris-
ing from the right meningohypophyseal trunk (MHT) 
(Fig. 2). The tumor was also fed partially by the right infe-
rolateral trunk, vidian artery, middle meningeal artery, 
left MHT, and inferolateral trunk. Preoperative emboli-
zation was planned based on the presumed diagnosis of 
giant pituitary adenoma with hypervascular nature.
Preoperative embolization
Transarterial embolization was performed via the femo-
ral approach under general anesthesia. After general hep-
arinization, a 7-F guiding catheter was inserted into the 
right internal carotid artery. A Marathon microcatheter 
(ev3, Irvine, MN, USA) was navigated selectively over a 
0.010-inch Chikai microwire (Asahi Intec, Nagoya, Aichi, 
Japan) into the right MHT branches supplying the tumor. 
Super-selective angiography demonstrated diffuse opaci-
fication of the lesion. These branches were occluded 
using 15 and 20% n-butyl cyanoacrylate. Post-emboliza-
tion angiography demonstrated marked devasculariza-
tion of the tumor (Fig.  3). Additionally, the feeder from 
Fig. 1 a Sagittal bone computed tomography image showing extensive destruction of the sella turcica. b Coronal T1-weighted magnetic reso-
nance image showing hypointense giant pituitary tumor. c, d Coronal (c) and sagittal (d) contrast-enhanced T1-weighted magnetic resonance 
images showing marked enhancement of the tumor
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the right middle meningeal artery was occluded using 
microcoils.
Surgical removal and postoperative course
The tumor removal was performed via an extended trans-
sphenoidal route in a two-stage operation. First surgery 
was performed on the same day of embolization as gross 
decompression to avoid mass effect of the tumor due to 
swelling of necrotizing tissue, and the following surgery 
was performed 18 days later expected easier removal of 
the tumor by simple aspiration. And subtotal removal was 
achieved without complications (Fig.  4). Intraoperative 
findings showed thick artery (about 500 μm of diameter) 
and mesh-like thinner arteries (around 150 μm of diam-
eter) ran inside the tumor, which were coagulated and 
devascularized one by one. The blood loss during the 
two operations was 671  mL in total. The postoperative 
course was uneventful, with remarkable improvements 
in her visual acuity and visual field. The prolactin level 
was normalized and she had no diabetes insipidus after 
operation. She was discharged 12  days after the second 
transsphenoidal surgery. Pathological analysis confirmed 
the diagnosis of null cell adenoma. The surgical policy 
was explained preoperatively to the patients and written 
Fig. 2 a, b Right internal carotid angiograms, anteroposterior (a) and lateral (b) views, showing the tumor mainly fed by the right meningohypo-
physeal trunk (arrow). c Sagittal maximum-intensity projection cone-beam computed tomography image showing a giant hypervascular pituitary 
tumor (arrowheads) with large feeders from the right meningohypophyseal trunk
Fig. 3 a, b Right internal carotid angiogram, oblique view, before (a) and after (b) embolization of the right meningohypophyseal trunk, showing 
the marked devascularization of the tumor. c Skull radiograph, oblique view, after embolization showing the cast of n-butyl cyanoacrylate (arrow-
heads)
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informed consents were obtained. Overall study design 
was approved by the Ethical Committee of Kohnan Hos-
pital 2015.
Discussion with conclusion
The primary goal of surgical treatment of giant pituitary 
adenoma is improvement of the visual, endocrinological, 
and neurological symptoms, whilst ensuring the lowest 
risk for morbidity and mortality rates. However, radical 
removal of giant pituitary adenomas remains a challenge 
for neurosurgeons despite the development of microsurgi-
cal techniques. Surgical management of giant adenoma has 
a higher complication rate than that of non-giant adenoma. 
The reported mortality and morbidity rates in surgical 
series of giant pituitary adenomas are 0–3.2 and 4.2–15.5%, 
respectively [1, 2, 7, 8]. Clival invasion is also associated 
with a higher rate of operative complications [9].
The most likely explanation for the worse surgical 
outcome is that resection of giant tumors is frequently 
incomplete, thus putting patients at increased risk 
of postoperative pituitary apoplexy occurring within 
the immediate postoperative period [4, 5]. Postopera-
tive pituitary apoplexy is usually associated with very 
poor outcomes due to significant postoperative tumor 
swelling, hemorrhage, infarction, necrosis precipitat-
ing further mass effect, cerebral edema, and herniation 
syndrome [1, 4, 5]. Giant pituitary adenomas have much 
more vascularity than non-giant pituitary adenomas 
[10], so that postoperative pituitary apoplexy may cor-
relate with such hypervascularity. In the present case, 
preoperative neuroimaging, including contrast-enhanced 
magnetic resonance imaging and angiography, suggested 
that the tumor was hypervascular. Therefore, we per-
formed preoperative embolization followed by two-stage 
transsphenoidal surgery. Although we could not com-
pletely remove the tumor extending into the cavernous 
sinus and clivus, the postoperative course was unevent-
ful without hemorrhagic complication after both stages 
of transsphenoidal surgery. We suggest that preoperative 
embolization of giant pituitary adenoma has the poten-
tial to prevent postoperative pituitary apoplexy.
Embolization facilitates tumor resection by limiting 
blood loss and softening the tumor, which result in a clear 
operation field and reduced forces transmitted to adja-
cent neural structures, making surgical resection safer 
[6, 11, 12]. The usefulness of preoperative embolization 
through the internal carotid artery branches is much less 
understood due to the technical difficulties and higher 
risks compared with embolization through the exter-
nal carotid artery branches [11, 13]. The risks include 
thromboembolic events, post-embolization cranial nerve 
deficits, intratumoral hemorrhage, post-embolization 
swelling, and general complications related to angiogra-
phy [13]. The recent development of the high-resolution 
road mapping system and concurrent development of 
softer and smaller microcatheters and microwires have 
enabled super-selective embolization through the inter-
nal carotid artery branches [14]. Major blood supply of 
giant pituitary adenomas originates from branches of 
the infraclinoidal portion of the internal carotid artery 
[15]. The MHT is generally very small and arises at an 
acute angle from the internal carotid artery, and these 
Fig. 4 a Axial computed tomography image obtained immediately after the first transsphenoidal surgery showing no hemorrhagic complication. 
b: Sagittal contrast-enhanced T1-weighted magnetic resonance image obtained 3 days after the second transsphenoidal surgery showing subtotal 
removal of the tumor
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anatomical relationships create challenges to direct cath-
eterization, but few clinical trials have investigated pre-
operative embolization of the MHT in meningiomas [13, 
14, 16]. Consequently, the surgical indications must care-
fully balance the risks against the potential benefit.
The present case describes the technique of preopera-
tive embolization of giant pituitary adenoma. No compli-
cations were observed and marked devascularization was 
achieved. The tumor was hypervascular, and was supplied 
by feeders such as thick branches of the MHT. We used 
n-butyl cyanoacrylate at a relatively low concentration, 
because we could insert the microcatheter into a distal 
portion of the MHT and could deliver embolic material 
deep inside the tumor. Use of n-butyl cyanoacrylate is 
very safe for the embolization of head and neck tumors 
[17]. Moreover, we planned to perform the emboliza-
tion and the immediate transsphenoidal surgery in a sin-
gle session before reconstitution of the collaterals to the 
occluded tumor area. Early surgical tumor removal can 
also reduce the risk of repeated general anesthesia and 
reduce other delayed reactions to tumor embolization 
such as mass effect of the tumor due to swelling with her-
niation or obstructive hydrocephalus [12]. Ischemic pitu-
itary adenoma apoplexy often leads to the progression of 
cranial nerve palsy and decreased level of consciousness 
[18]. Control of intraoperative bleeding was effective, and 
intraoperative blood loss was low, resulting in successful 
staged transsphenoidal surgery without complications. 
The present case demonstrates that preoperative emboli-
zation of giant pituitary adenoma should be regarded as a 
feasible option to decrease surgical blood loss.
In conclusion the present case illustrates the useful-
ness and feasibility of preoperative embolization of giant 
pituitary adenomas. Recent advances in microcatheter, 
microguidewire, and imaging technology may allow the 
introduction of new therapeutic strategies and indica-
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